Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?

A. Casadevall, D. L. Goldman, M. Feldmesser

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalBulletin de l'Institut Pasteur
Volume95
Issue number4
DOIs
Publication statusPublished - Jan 1 1997

Keywords

  • Antibiotic resistance
  • HIV
  • Immunoglobulin
  • Opportunistic infection
  • RSV
  • Review
  • Septic shock
  • Therapeutics

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology

Cite this